TFF is a Texas-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic respiratory diseases...
Read moreTFF is a Texas-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic respiratory diseases...
Read moreAnnual Revenue
$ < 1M
TFF's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 294.5M. Over the last four quarters, TFF's revenue has grown by 630.1%. Specifically, in Q3 2022's revenue was $ < 1M; in Q2 2022, it was $ < 1M; in Q1 2022, it was $ < 1M; in Q4 2021, TFF's revenue was $ < 1M.